AI Tool Similar to Radiologists for Interpreting Chest Radiographs
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 10, 2023 -- An artificial intelligence (AI) tool for interpreting chest radiographs produces reports that are not significantly different from those of radiologists, according to a study published online Oct. 5 in JAMA Network Open.
Jonathan Huang, from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues conducted a retrospective diagnostic study of 500 randomly sampled emergency department encounters at a tertiary care institution, including chest radiographs interpreted by both a teleradiology service and on-site attending radiologist. For each radiograph, an AI interpretation was also generated. The three radiograph interpretations were each rated by six emergency department physicians using a Likert scale (5 points).
The researchers observed a significant association of report type with ratings, with significantly greater scores for AI and radiologist versus teleradiology reports (mean score, 3.22 and 3.34, respectively, versus 2.74). No significant differences were seen between AI and radiologist reports. In a secondary analysis, no difference was seen in the probability of no clinically significant discrepancy between the three report types. No difference in the probability of containing no clinically significant discrepancy between the report types was seen on further stratification of reports by presence of cardiomegaly, pulmonary edema, pleural effusion, infiltrate, pneumothorax, and support devices.
"Model integration in clinical workflows could enable timely alerts to life-threatening pathology while aiding physician imaging interpretation and speeding up documentation," the authors write. "Further efforts to prospectively evaluate clinical impact and generalizability are needed."
Several authors reported having equity ownership in Cardiosense.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.